the purine analog 2',3'-dideoxyinosine ( ddi ) , which has anti-retroviral activity in vitro was administered for up to 42 weeks to 26 patients with acquired immunodeficiency syndrome ( aids ) or severe aids-related complex ( arc ) .
C0012133
ddi
C0001175
aids